Exclusive: Kivo Health nabs $10M for lung disease

Seattle-based Kivo Health raised $10 million in Series A funding to expand its virtual care services for people living with chronic lung disease. The company focuses on helping older adults with chronic obstructive pulmonary disease (COPD) access rehabilitation and ongoing care from home, making treatment more convenient for patients who may have difficulty traveling to appointments.
 
Led by Allumia Ventures, the funding round included investments from Corewell Health Ventures, Y Combinator, Heuristic Capital and MassMutual Ventures, bringing Kivo’s total funding to more than $16 million. The company provides patients with equipment to monitor their health and participate in virtual appointments with respiratory specialists, helping them manage their conditions outside traditional hospital settings.
 
The investment supports the growth of a Washington-based health technology company working to make specialized care more accessible, demonstrating how Seattle startups are developing new approaches to meeting patients’ needs.
 

READ THE STORY at Axios »